Artificial Intelligence
Demand for Global Digital Pathology Market Size & Share Worth USD 1738.82 Million by 2028, Exhibit a 13.8% CAGR Growth | Digital Pathology Industry Trends, Analysis & Forecast Report by Facts & Factors
NEW YORK, United States, March 31, 2022 (GLOBE NEWSWIRE) — Facts and Factors has published a new research report titled “Digital Pathology Market by Product (Scanners, Software, Communication Systems, and Storage Systems), By Type (Human Pathology, Veterinary Pathology), By Application (Drug Discovery, Disease Diagnosis, Training & Education, and Tele-consultation), By End User (Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Labs, and Academic & Research Institutes): Global Industry Perspective, Comprehensive Analysis, and Forecast 2022 – 2028” in its research database.
“According to the latest research study, the demand of global Digital Pathology Market size & share was witnessed USD 740.26 million in 2021 and it is expected to surpass around USD 1738.82 million Mark, by 2028, at a compound annual growth rate (CAGR) of about 13.8% during the forecast period 2022 to 2028.” The rising number of pathologists, the benefits of digital pathology, and its rapid adoption in the healthcare industry are expected to boost market demand over the forecast period.
What is Digital Pathology? How big is the Digital Pathology Market?
Market Overview:
Digital pathology is a diagnosis carried out by the use of various computer technologies. Digitized specimen slide generates information that is managed by advanced computation and through virtual microscopy. Advancement in genetic science, medical science as well as computer technology together hand in hand has developed the subfield of pathology called digital pathology. During disease diagnosis, digitization of pathology is performed at hospitals, diagnostic centers. It offers a high-resolution sample scanning, analysis of computer images, and online storage of digital slides which enables pathologists to examine slides without forensic evidence
Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs – https://www.fnfresearch.com/sample/digital-pathology-market
(A free sample of this report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the Following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
- The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
- About 215+ Pages Research Report (Including Recent Research)
- Provide detailed chapter-by-chapter guidance on Request
- Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022
- Includes Tables and figures have been updated
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
- Facts and Factors research methodology
(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)
Report Scope
| Report Attribute | Details |
| Market Size in 2021 | USD 740.26 Million |
| Projected Market Size in 2028 | USD 1738.82 Million |
| CAGR Growth Rate | 13.8% CAGR |
| Base Year | 2021 |
| Forecast Years | 2022-2028 |
| Key Market Players | Koninklijke Philips N.V., Hamamatsu Photonics, Leica Biosystems, Visiopharm A/S, Corista, Indica Labs, OptraSCAN, Glencoe Software, Inspirata Inc., Mikroscan Technologies, Proscia Inc., Kanteron Systems, Roche, Apollo Enterprise Imaging, Sectra AB, and Huron Digital Pathology among others. |
| Key Segment | By Product, By Type, By Application, By End User, and By Region |
| Major Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
| Purchase Options | Request customized purchase options to meet your research needs. Explore purchase options |
Global Digital Pathology Market Growth Factors
- Rising Prevalence of Chronic Conditions
The increasing prevalence of chronic conditions is projected to increase clinical urgency to take digital pathology in order to improve the current poor diagnostic imaging measures and to reduce the high cost of conventional diagnostics. As per the survey, the total number of chronic respiratory disease cases increased by 39.5% between 1990 to 2017. At COVID-19, a Digital Pathology Enforcement Policy for Pathologists, clinical laboratories, healthcare centers, and drug management staff was issued by the US FDA’s Center for Devices and Radiological Health. The document sets out a policy framework for increasing the availability of digital devices for remote pathology in such a critical situation. Supportive regulations are expected to have a positive impact on the market in the coming years.
Browse the full “Digital Pathology Market by Product (Scanners, Software, Communication Systems, and Storage Systems), By Type (Human Pathology, Veterinary Pathology), By Application (Drug Discovery, Disease Diagnosis, Training & Education, and Tele-consultation), By End User (Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Labs, and Academic & Research Institutes): Global Industry Perspective, Comprehensive Analysis, and Forecast 2022 – 2028” Report at https://www.fnfresearch.com/digital-pathology-market
Digital Pathology Market Segments Analysis
The global digital pathology market is segmented on the basis of product, type, application, and end-user.
- The scanners segment was expected to account for the majority of the market share
On the basis of Product, the global digital pathology market is segmented into scanners, software, communication systems, and storage systems. In 2020, the scanners segment was expected to account for the majority of the market share. The software segment, on the other hand, is predicted to grow at the fastest rate between 2021 and 2028. The scanner aids in the production of rapid, dependable, and high-resolution photographs of cell nuclei.
On the basis of type, the global market is categorized into human pathology, veterinary pathology. By application segment, the global digital pathology market is divided into drug discovery, disease diagnosis, training & education, and teleconsultation. In 2020, the drug discovery category was expected to account for the biggest percentage of the market overall. During the year 2021–2028, the same segment, on the other hand, is predicted to post the greatest CAGR.
- Pharmaceutical and biotechnology companies are expected to dominate the market during the forecast period
By end-user, the market is classified into hospitals, pharmaceutical & biotechnology companies, diagnostic labs, and academic & research institutes. Pharmaceutical and biotechnology companies are expected to dominate the industry in 2020. By 2028, the same category is predicted to be the market’s largest shareholder. Pharmaceutical and biotechnology companies are digitizing their work. Companies are continually searching for new chemicals and biomarkers. In addition, digital pathology facilitates data interchange between pharmaceutical corporations and R&D labs. Due to the causes listed above, the market for pharma and biotech firms is expected to rise in the future years.
Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/digital-pathology-market
Who are the Top Market Players in Digital Pathology Market?
Competitive Landscape
A large selection of diagnostic products is available from manufacturers, who are concentrating on product development. Furthermore, leading players in the digital pathology market are concentrating on expanding their global and regional footprint through acquisitions and international expansion on an international scale.
Some of the main competitors dominating the global digital pathology market include –
- Koninklijke Philips N.V.
- Hamamatsu Photonics
- Leica Biosystems
- Visiopharm A/S
- Corista
- Indica Labs
- OptraSCAN
- Glencoe Software
- Inspirata Inc.
- Mikroscan Technologies
- Proscia Inc.
- Kanteron Systems
- Roche
- Apollo Enterprise Imaging
- Sectra AB
- Huron Digital Pathology
Key Insights from Primary Research:
- As per the analysis shared by our research team, the digital pathology market is estimated to grow at a CAGR of around 13.8% between 2022 and 2028.
- The digital pathology market was valued at around USD 740.26 Million in 2021 and is projected to reach around USD 1738.82 Million, by 2028.
- By Product, The software segment is predicted to grow at the fastest rate during the forecast timeline.
- By 2028, the Pharmaceutical and biotechnology companies segment is predicted to be the market’s largest shareholder based on the end-user segment.
- On the basis of region, the North American region is expected to dominate the global digital pathology market.
Key questions answered in this report:
- What is the market size and growth rate forecast for the Digital Pathology industry?
- What are the main driving factors propelling the Digital Pathology Market forward?
- What are the leading companies in the Digital Pathology Industry?
- What segments does the Digital Pathology Market cover?
- How can I receive a free copy of the Digital Pathology Market sample report and company profiles?
Have Any Query? Ask Our Experts: https://www.fnfresearch.com/inquiry/digital-pathology-market
COVID-19 Impact on Digital Pathology Market:
The COVID-19 pandemic is expected to have a beneficial impact on the worldwide digital pathology industry. The FDA’s Center for Devices and Radiological Health issued an enforcement policy for remote digital pathology devices aimed at pathologists, clinical laboratories, and drug administration personnel. As a result of the growth in chronic disease cases, the use of digital pathology systems for diagnosis has risen, which is expected to boost the digital pathology market over the forecast period (2022-2028).
As a result, new developments by leading competitors and an increased number of product approvals drive market growth. However, the high cost of digital pathology equipment is projected to stymie market expansion during the projected timeframe.
Which region offers the best opportunity and growth in Digital Pathology Market?
Regional Dominance:
- North America is Projected to Dominate the Global Digital Pathology Market
North America accounted for the major market share among the others, and it has been expected to maintain this trend in the near future, owing to the huge adoption of digital pathology systems. Moreover, the easy accessibility of digital pathology products and the growing need for digital pathology over the traditional methods fuel the market growth. Asia-Pacific is expected to record the highest rate of growth over the next few years due to a rise in awareness of digital pathology systems. The presence of a large patient base with chronic & infectious diseases and an increase in expenditure on healthcare infrastructure will support the market growth during the forecast timeline. Moreover, the ever-changing life science sector is predicted to offer lucrative market expansion opportunities in developing economies such as China, India, and Malaysia.
Recent Developments
- September 2021: In a joint venture, Visiopharm (Denmark) and Agilent Technologies, Inc. (US) will commercialize Visiopharm’s CE-IVD-certified AI-driven Precision Pathology software alongside Agilent’s automated pathology staining solutions.
- August 2021: In a signed agreement, Sectra AB (Sweden) and the University Medical Center Utrecht (Netherlands) agreed that UMC will use Sectra’s pathology module to facilitate productive interdisciplinary conversations between pathologists and radiologists at the hospital.
- April 2021: For nations throughout North America and Europe, Leica Biosystems and Paige.AI, Inc. (US) have teamed up to bring Paige’s artificial intelligence-powered research tools for tumor detection, grading, and quantification to the Leica Biosystems digital pathology platform.
Request for Customization on this Report as per your requirements – https://www.fnfresearch.com/customization/digital-pathology-market
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customizing your report.)
The global digital pathology market is segmented as follows:
By Product
- Scanners
- Software
- Communication Systems
- Storage Systems
By Type
- Human Pathology
- Veterinary Pathology
By Application
- Drug Discovery
- Disease Diagnosis
- Training & Education
- Tele-consultation
By End-User
- Hospitals
- Pharmaceutical & Biotechnology Companies
- Diagnostic Labs
- Academic & Research Institutes
Request for Free Sample Report of the Global Digital Pathology Market @ https://www.fnfresearch.com/sample/digital-pathology-market
Browse Other Related Research Reports from Facts & Factors
Digital Remittance Market | The global digital remittance market was worth around USD 15.27 billion in 2021 and is estimated to grow to about USD 36.54 billion by 2028, with a compound annual growth rate (CAGR) of approximately 14.6% over the forecast period.
Digital Banking Market | The global Digital Banking Market size & share report will be valued at USD 13.9 Billion in the year 2026 from an initial value of USD 7.9 Billion in the year 2020 at a CAGR value of 9.9%.
Digital Transformation Consulting Market | The global digital transformation consulting market is expected to grow at a CAGR of around 7.5% from 2021 to 2026. The digital transformation consulting market was valued at around USD 5 Billion in 2020 and is expected to rise above USD 11 Billion by 2026.
Digital Health Market | The global digital health market was valued at approximately USD 84.08 Billion in 2019 and is expected to generate revenue of around USD 220.94 Billion by end of 2026, growing at a CAGR of around 14.8% between 2020 and 2026.
Digital Oscilloscope Market | The global digital oscilloscope market generated revenue of around USD 1913.6 Million in 2019 and is projected to reach USD 2825 Million by 2026, growing at a CAGR of 5.4% between 2020 and 2026.
Digital Talent Acquisition Market | The global digital talent acquisition market in 2019 was approximately USD 28.3 billion. The market is expected to grow at a CAGR of 10.27% and is anticipated to reach around USD 57.49 billion by 2026.
About Facts & Factors:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us on LinkedIn: https://www.linkedin.com/company/fnfresearch
Follow Us on Twitter: https://twitter.com/fnfresearch
Follow Us on Facebook: https://www.facebook.com/factsandfactors/
Contact Us:
Sanu Thomas
USA: +1 347 690-0211
United Kingdom: +44 2032 894158
Japan: +81 50 5806 9039
India: +91 96043 17127
Email: [email protected]
Web: https://www.fnfresearch.com
Blog: https://www.fnfresearch.com/blog/
Artificial Intelligence
Sentrycs Secures Multimillion-Dollar Deals to Protect Military Bases in Europe
Sentrycs’ technology-leading counter-drone solutions have been chosen to enhance the protection of military bases in Europe against small and commercial drones
TEL AVIV, Israel, May 29, 2024 /PRNewswire/ — Sentrycs – a global technology leader in the cyber-based RF segment of counter-drone solutions – announced strategic deals which will see the implementation of its advanced counter-UAS (Unmanned Aerial Systems) solutions across multiple military bases throughout Europe.
The field-proven Israeli technology provider will enable its customers to mitigate the immediate threats from small and commercial drones performing ISR (Intelligence, Surveillance, and Reconnaissance) missions over sensitive sites including military bases, and occasionally attacking forces as demonstrated in recent years in Ukraine-Russia conflict and in the Middle East.
Sentrycs solutions, employing proprietary protocol analysis technology, can passively detect those drones, track their flight, identify their model, unique serial number, and ID, enabling distinction between friendly and enemy drones. Once a drone becomes a threat, the system neutralizes the drone, landing it safely in a predefined zone.
The systems will be deployed either as a standalone or as an integral part of broader multi-layered C-UAS solution to enable effective protection against different kinds of drones.
“Winning these projects signifies a meaningful market recognition of Sentrycs’ unique capabilities and technology leadership,” said Yoav Zaltzman, CEO of Sentrycs. “Our commitment to ongoing innovation and our agility in adapting to the fast-changing threats, along with strong customer support allow us to provide a field-proven and effective long-term solution. We are proud to contribute to the security of our allies with our advanced counter-drone solutions.”
ABOUT SENTRYCS:
Sentrycs is a leader in adaptive counter-drone solutions, supported by innovative cyber over RF technology. Sentrycs field-proven solutions are designed to passively detect, track, identify, and where necessary, mitigate unauthorized drones. It is custom-built for various environments, including airports, borders, prisons, critical infrastructure, and mass events. Founded in 2017, Sentrycs has offices in Israel and the US, serving customers worldwide. By uniting its field-proven technology and expertise in global drone environments, Sentrycs is leading the way toward a safer and more secure drone-driven future. Learn more at www.sentrycs.com.
Photo: https://mma.prnewswire.com/media/2422731/Sentrycs_Portable_Kit.jpgPhoto: https://mma.prnewswire.com/media/2422732/Sentrycs.jpgLogo: https://mma.prnewswire.com/media/2422730/Sentrycs_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/sentrycs-secures-multimillion-dollar-deals-to-protect-military-bases-in-europe-302157168.html
Artificial Intelligence
SciBase Announces the launch of eBarrier Score, the First AI-Driven Skin Barrier Assessment tool for research and Cosmetic Testing
STOCKHOLM, May 29, 2024 /PRNewswire/ — SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of artificial intelligence (AI)-based solutions for skin disorders is pleased to announce the launch of the eBarrier Score for Nevisense, the first-ever AI skin barrier assessment tool built for use in research and cosmetic testing. The eBarrier Score was announced today at the Cosmetotest cosmetic testing symposium in Lyon, France.
Researchers of the skin barrier and cosmetic products can now use Nevisense and the eBarrier Score to assess products and claims related to skin barrier function. The global market for cosmetic products aiming to improve people’s skin barrier is experiencing immense growth.
Nevisense and the eBarrier Score utilize AI-generated algorithms that researchers can use to directly quantitate the severity of skin barrier dysfunction related to common skin disorders.
In a recently published study (Skin Barrier Function Assessment: Electrical Impedance Spectroscopy Is Less Influenced by Daily Routine Activities Than Transepidermal Water Loss – https://anndermatol.org/DOIx.php?id=10.5021/ad.23.052) the first direct comparison between electrical impedance spectroscopy (EIS) using Nevisense and trans-epidermal water loss (TEWL) was made. The study demonstrates Nevisense being a more robust technique to assess skin barrier function than the within research commonly used TEWL measurement technique.
“We are thrilled to introduce the eBarrier Score to the cosmetic research market,” said Pia Renaudin, CEO of SciBase. “Every day, there are new cosmetic products related to skin barrier function. The Nevisense eBarrier Score is already an established tool in the medical research field and bringing it to the cosmetic research market will truly benefit consumers.”
For more information on the eBarrier Score and SciBase’s other research or medical products, visit scibase.com. In February SciBase announced a partnership with Skinobs, a leading global platform connecting researchers with the tools they need for their cosmetic and medical research. Through this partnership, SciBase can now offer Nevisense and eBarrier for assessing skin barrier function within cosmetic testing on the Skinobs platform.
For additional information, please contact:Pia Renaudin, VD, tel. +46732069802, e-mail: [email protected] Advisor (CA):Vator SecuritiesTel: +46 8 580 065 99Email: [email protected]
About SciBase:
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at www.scibase.com. All press releases and financial reports can be found here: http://investors.scibase.se/en/pressreleases
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/scibase/r/scibase-announces-the-launch-of-ebarrier-score–the-first-ai-driven-skin-barrier-assessment-tool-for,c3990203
The following files are available for download:
https://mb.cision.com/Main/12371/3990203/2828415.pdf
eBarrier Score PR
View original content:https://www.prnewswire.co.uk/news-releases/scibase-announces-the-launch-of-ebarrier-score-the-first-ai-driven-skin-barrier-assessment-tool-for-research-and-cosmetic-testing-302157613.html
Artificial Intelligence
Warmflow to see more actionable real-time operational insights and better forecasting with Plex Smart Manufacturing Platform from Rockwell Automation
Irish family-owned home heating technology company to leverage cloud-based ERP, QMS & MES to empower its employees and enhance digital capabilities
BRUSSELS, May 29, 2024 /PRNewswire/ — Rockwell Automation, Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced that Warmflow, an innovative home heating technology company based in Lisburn, Northern Ireland, is to be the first company in Ireland to deploy the Plex ERP, QMS & MES solution from Rockwell Automation.
Established in 1970, Warmflow, a family-owned business, is committed to digital innovation. By adopting the Plex Smart Manufacturing Platform™, it is positioned to optimize operations, enhance efficiency, and stay ahead in an evolving marketplace. The Plex solution will replace several disparate systems with MES (manufacturing execution systems), ERP (enterprise resource planning), and QMS (quality management systems) under Plex’s single-platform cloud-based umbrella.
Primary outcomes are to include a significant reduction of capital investment in stock and more accurate production planning, both of which will be possible thanks to the real-time insight-driven forecasting.
“Warmflow is an ideal customer for our Plex solution,” said Asa Arvidsson, regional vice president north region, Rockwell Automation. “It is well suited for mid-size companies to support cross-functional processes, such as ERP, MES and QMS, and to deliver a single, integrated, and intuitive view of manufacturing operations. Its cloud-based architecture also makes it eminently scalable and faster to implement.”
The digital transformation project – including new sequencing automation, control, I/O, and associated code – was developed in collaboration with ControlSoft Automation Systems, a member of the Rockwell Automation PartnerNetwork™ ecosystem as a gold-level system integrator. ControlSoft is an industrial automation company based in Dundalk, Co. Louth, Ireland, that provides turnkey solutions for process control, machine control, information, and energy control for many industries.
An important element of this turnkey project was the development of a value engineering assessment report that examined the current situation and then compared it with typical results from the Plex solution over a five-year period. Substantial savings and a rapid return on investment (ROI) were immediately apparent by removing scheduling and stockholding pain points and providing more efficient automated data handling.
“We are a family-owned business, providing innovative heating solutions to the community for the last 50 years, so it’s important we select the right ERP, QMS & MES partner as we take our next step towards the next 50 years,” explains Stewart Mclaughlin, manufacturing director at Warmflow. “Like any company we face operational challenges, and Rockwell Automation gives us a solution to these with its Plex software all-in-one solution. Its forecasting gives us room for advancement too, as we will be able to better schedule our highly qualified engineers and designers for more R&D work on our new, more-sustainable geothermal and heat-pump technologies.”
All elements of this digital solution integrate seamlessly with each other, with further operational value added by a unified LifecycleIQ Services contract for the hardware and software solutions, giving Warmflow a single point of contact for support for its new digitalized infrastructure.
About Rockwell AutomationRockwell Automation, Inc. (NYSE: ROK), is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 29,000 problem solvers dedicated to our customers in more than 100 countries. To learn more about how we are bringing Connected Enterprise to life across industrial enterprises, visit www.rockwellautomation.com.
Logo – https://mma.prnewswire.com/media/1981317/Rockwell_Automation_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/warmflow-to-see-more-actionable-real-time-operational-insights-and-better-forecasting-with-plex-smart-manufacturing-platform-from-rockwell-automation-302151516.html
-
Artificial Intelligence5 days agoTitans of Tech: GP Bullhound releases its annual report on the European tech ecosystem
-
Artificial Intelligence5 days agoBybit Web3 Announces Upcoming IDO for Aperture Finance, Simplifying Web3 Finance
-
Artificial Intelligence7 days agoHONOR Unveils Four-Layer AI Architecture and Forges Ahead with Google Cloud for More AI Experiences at VivaTech 2024
-
Uncategorized5 days agoGienTech Hosted the “2024 GienTech Digital Transformation Conference” to Promote Overseas Collaborative Ecosystem Development
-
Uncategorized5 days ago
Hyreo ushers in a New Dawn for Recruitment Technology with Hyreo Labs
-
Artificial Intelligence5 days agoIoT Node and Gateway Market worth $604.7 billion by 2029 – Exclusive Report by MarketsandMarkets™
-
Artificial Intelligence5 days agoOverseas Expansion Strategy of K-OTT Introduced in France, KOCCA holds the ‘2024 Korea-France Content Forum’
-
Artificial Intelligence5 days agoatNorth Wins ‘Colocation Provider of the Year’ and ‘Digital Infrastructure Project of the Year’ at Industry Award Events
